Drugmakers Create Mobile Phone Apps to Track Diabetes, Cancer

Drugmakers led by Merck & Co. and Novartis AG boosted investments in mobile phone applications and educational websites by 78 percent to get patients to take their drugs, eat right and exercise, an Ernst & Young report found.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.